Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_927_Библиотеки_им_академика_М_И_Перельмана.pdf
Скачиваний:
0
Добавлен:
31.08.2026
Размер:
31 Мб
Скачать
ANAL AND PERIANAL REGION 11

S u g g e S t e d R e a d i n g

Bollard RC, Gardiner A, Lindows S, etal. Normal female anal sphincter. Dif-
culties in interpretation explained. Dis Colon Rectum. 2002;45:171–175.
Canessa CE, Miegge LM, Bado J, etal. Anatomic study of lateral pelvic lymph
nodes: implications in the treatment of rectal cancer. Dis Colon Rectum. 2004;47:297–303.
Carty NJ, Moran B, Johnson CD. Anorectal physiology measurements are of
no value in clinical practice. True or false? Ann R Coll Surg Engl. 1994;76: 276–280.
Church JM, Raudkivi PJ, Hill GL. e surgical anatomy of the rectum—a
review with particular relevance to the hazards of rectal mobilization. Int J Colorectal Dis. 1987;2:158–166.
Goligher JC. e blood supply to the sigmoid colon and rectum. Br J Surg.
1949;37:157–162.
Gordon PH, Nivatvongs S. Principles and Practice of Surgery for the Colon,
Rectum and Anus. 3rd ed. New York: Informa Healthcare USA; 2007.
Havenga K, De Ruiter MC, Enker WE, Welvaart K. Anatomical basis of au-
tonomic nerve-preserving total mesorectal excision for rectal cancer. Br J Surg. 1996;83:384–388.
Heald RJ, Meran BJ. Embryology and anatomy of the rectum. Semin Surg On-
col. 1998;15:66–71.
Lubowski DZ, Meagher AP, Smart RC, Butler SP. Scintigraphic assessment
of colonic function during defecation. Int J Colorectal Dis. 1995;10:91–93.
Matzel KE, Schmidt RA, Tangho EA. Neuroanatomy of the striated muscular
and anal mechanism. Implications for the use of neurostimulation. Dis Colon Rectum. 1990;33:666–673.
Miscusi G, Masoni L, Dell’Anna A, Montori A. Normal lymphatic drainage of
the rectum and the anal canal revealed by lymphoscintigraphy. Coloproc- tology. 1987;9:171–174.
Yamaguchi S, Kuroyanagi H, Milson JW, Sim R, Shimada H. Venous anatomy
of the right colon. Precise structure of the major veins and gastrocolic trunk in 58 cadavers. Dis Colon Rectum. 2002;45:1337–1340.
H
Anthony J. Senagore
emorrhoids are vascular cushions that lie close to the anus and
H
are subject to the stresses and strains of defecation. ey are normal structures that become symptomatic when thrombosis or prolapse develops as a result of either a congenital weakness in the area or because of excessive or repeated straining. e challenges of managing patients with symptomatic hemorrhoids include making a correct diagnosis, persuading patients to improve their defecatory habits, and using the appropriate procedure to manage the problem at hand. In this chapter, external and internal hemorrhoids will be considered separately.

EXTERNAL HEMORRHOIDS

e external hemorrhoidal plexus is a network of veins that run around the anus at the anal verge. e veins become symptomatic when they thrombose. Resolution of external hemorrhoid throm­bosis may predispose to anal tags that are usually asymptomatic but are typically excised along with prolapsing internal hemorrhoids. Acute thrombosis of the external hemorrhoidal plexus is a painful condition that tends to follow straining, either during liing, child­birth, or defecation. Aected patients are in considerable pain and have an edematous lump at the anal verge caused by the clot. Oen the blue color of the clot conrms the diagnosis. Surgical excision of acutely thrombosed external hemorrhoids is warranted when the thrombosis is large, painful, and identied within 72 hours of onset. Sometimes the clot ulcerates through the skin and patients experi­ence anal bleeding independent of bowel habits, with partial easing of the pain. is presentation is another indication for surgery. Small external hemorrhoidal thromboses are easily managed in the oce setting with a local anesthetic and complete excision of the clot and vein, with or without skin closure. More extensive thromboses should be excised with use of a general anesthetic to allow careful planning of the excision and preservation of the anoderm. 
ANATOMY AND ETIOLOGY OF
INTERNAL HEMORRHOIDS
Internal hemorrhoids are vascular cushions lying above the dentate line under the mucosa of the low rectum. e classic orientation of the hemorrhoidal cushions is right anterior, right posterior, and le lateral, although intervening secondary hemorrhoidal complexes may blur this classic anatomy. e arterial blood supply, which contributes to the frequent symptom of bright red rectal bleeding, is derived from the superior rectal artery, a branch of the inferior mesenteric artery, the middle rectal arteries arising from the internal iliac arteries, and the inferior rectal arteries arising from the pudendal arteries. Above the dentate line the venous drainage enters the portal venous system, whereas below the dentate line it passes to the systemic venous sys­tem. is vascular anatomy creates the cushions that contribute to
12
anal continence and can be damaged by excessive straining, leading to the prolapse and bleeding typical of symptomatic hemorrhoids.
An understanding of the stages of hemorrhoidal pathophysiology is the basis for developing a strategy for management of symptomatic hemorrhoids. e staging system is shown in Box 2-1. At the earliest stage of disease, transudation of blood through thin-walled, damaged veins and/or arterioles presents primarily as painless bleeding and can be managed with astringents or local ablation of the vessels. Later, as the damage progresses to signicant disruption of the mucosal sus­pensory ligament, a technique capable of relocating the prolapsing tissue to its normal location and xing the tissue at that location will be required. 

CLINICAL EVALUATION

e typical constellation of hemorrhoidal symptoms includes bleed­ing, protrusion, and pain. However, only about one third of all patients with anorectal symptoms will actually have hemorrhoids as the cause of their symptoms. Hemorrhoidal bleeding, which typically occurs aer bowel movements, is painless and visible as bright red blood either on the toilet paper or in the commode. e bleeding can become more severe as the hemorrhoids enlarge and are either partially or completely trapped in a prolapsed position. Patients with tight internal sphincters are prone to magnied hemorrhoidal symp­toms because of the increased pressure in the anus. e history then addresses bowel habits, the frequency of straining upon defecation, recent changes in medications, diet, or lifestyle, and the presence of a family history of colorectal cancer. e patient should be asked about prior procedures performed to treat hemorrhoids, although the answer must be taken with a grain of salt unless it is supported by medical records.
Examination of the patient with hematochezia, although tailored by the age of the patient, should include sucient investigations to rule out a proximal source of bleeding such as inammatory bowel disease or neoplasia. Hemorrhoids should not be accepted as the cause of iron deciency anemia because this cause is rare.
First, a careful digital examination of the anal canal and distal rectum should be performed, including palpation of the prostate in men. Inspection of the anus may reveal skin tags, bulging external hemorrhoidal cushions (clues to the presence of internal hemor­rhoidal prolapse), or fourth-degree internal hemorrhoids. Other conditions may be present that mimic or co-exist with hemorrhoids, such as anal excoriation, anal neoplasms, condylomata, or ssure. If the patient does not have a ssure, an anoscopy is performed to determine the size and degree of prolapse of the hemorrhoids. Pok­ing the cushions with a cotton-tipped swab gives an impression of the degree of redundancy and the suitability of the hemorrhoid for elastic band ligation. White plaques on the hemorrhoids (pseudo­epitheliomatous hyperplasia) are an indication of chronic prolapse. Hemorrhoids should be classied as previously described to dene
ANAL AND PERIANAL REGION 13
BOX 2-1: The Standard Classification for Internal
Hemorrhoidal Diseases
Grade I = bleeding Grade II = protrusion with spontaneous reduction Grade III = protrusion requiring manual reduction Grade IV = irreducible protrusion of hemorrhoidal tissue
the degree of mucosal irritation, prolapse, columns involved, and associated anal skin tags. If the patient has presented with bleeding, has an increased risk for colorectal cancer, or is at average risk but is overdue for screening, a colonoscopy is requested. No physical treat­ment should be performed without clearing the colon, because drop metastases from a cancer proximal to an anal canal wound can occur. 

NONEXCISIONAL OPTIONS

Medical Management
Many patients with symptomatic hemorrhoids strain during def­ecation for several reasons. If the straining is due to small-volume stools, they need more roughage in their diet. If the straining is due to hard stools, they need more roughage and perhaps a properistaltic agent such as prune juice. If the straining occurs because defecation is deferred, they need to respond to the urge to defecate when it is rst perceived and not shut it down. An analysis of defecation and dietary habits and correction of problematic habits with the aim of avoiding straining may eliminate symptoms and allow patients to avoid a procedure. Correction of problematic habits is important in all patients, however, because straining aer banding and aer a hemorrhoidectomy may lead to recurrent symptoms. In at least 50% of patients, symptomatic internal hemorrhoids can be successfully managed by improving bowel habits. 
Sclerotherapy
Sclerotherapy of symptomatic internal hemorrhoidal disease has been performed since the nineteenth century and remains a highly eective, low-risk means of managing stage I hemorrhoids. Treat­ment produces local tissue destruction, which simultaneously ablates small vessels in the submucosa and creates tissue xation and atrophy of the hemorrhoidal complex. e sclerosing agents most commonly used are sodium morrhuate and sodium tetradecyl sulfate. Briey, the procedure involves anoscopic identication of the hemorrhoidal complex followed by instillation of the sclerosant into the submucosa above the level of the dentate line using a 25-gauge spinal needle. Typically, 1 to 2 mL of sclerosant per location is adequate, and mul­tiple locations can be treated during a single session. 
Energy-Based Destruction
the cost to acquire the machines and cleaning requirements between procedures should be considered. 
Hemorrhoidal Ligation with Rubber Bands
In 1963, Barron became the rst person to describe treatment of hemorrhoids with rubber bands. is technique has withstood the test of time, with multiple large-scale studies documenting both safety and ecacy, and it is a good option for grade II and III internal hemorrhoids. When the bands are applied correctly, pain is minimal both during and aer the procedure.
Banding is best performed with the patient in a prone jackknife position. Anoscopy is performed to assess the degree of hemorrhoidal prolapse and to establish the sites of the worst and the least prolapse. A set of two bands is applied above the dentate line at the top of the hemorrhoidal column by pulling the prolapsing tissue into the appli­cator. An assistant is needed to hold the anoscope and may help by slightly easing it out when the hemorrhoid is pulled or sucked into the applier. e worst aected hemorrhoid is treated rst, followed by the next worst aected hemorrhoid. It is wise to place a maximum of three sets of bands at once because discomfort due to the tight­ness can become severe. Patients are warned to expect to feel an urge to defecate aer banding that may be quite uncomfortable and will last the remainder of the day. Some patients may experience vasova­gal symptoms aer banding and thus patients should be asked to lie down for 10 minutes aer the procedure.
Discomfort immediately aer band placement may be reduced with the injection of a local anesthetic agent; however, this injection does not appear to provide a long-lasting benet. Banding is associ­ated with hemorrhage from the ulcers that occur at the band sites. is outcome is uncommon but can occur within the rst 2 weeks of the procedure; it seems to be more likely if a large amount of tissue is pulled into the band. e presence of acute pain aer banding means that the bands have been applied too low and sensory epithelium has been included in the band, in which case the bands should be removed. Finally, a rare but potentially fatal complication of peri­neal sepsis can occur, which is heralded by the symptoms of increas­ing rectal pain, fever, and the inability to void urine. It is essential to evaluate patients with these symptoms early and to treat them aggressively with broad-spectrum antibiotics and aggressive surgical drainage. e full eect of the bands is not noted for a month, by which time the ulcers at the sites of the band application have healed and scarring has occurred.
Bayer and colleagues reported a series of 2934 patients who underwent elastic band treatment of internal hemorrhoids, with 79% experiencing complete relief of symptoms aer a single session with treatment of only one or two locations. Multiple sessions were needed as follows: 2 sessions, 32%; 3 sessions, 17%; 4 sessions, 25%; and 5 sessions, 20%. Although the need for multiple sessions is a negative aspect of this technique, only 2.1% of patients required an excisional hemorrhoidectomy. Banding oers sustained, inexpensive relief of symptoms, with 69% of patients maintaining long-term relief and only 7.5% ultimately requiring an excisional hemorrhoidectomy. 
Bipolar diathermy converts electrical current into heat energy to coagulate the hemorrhoidal tissue, including the mucosa and sub­mucosa. e machine generates a 2-second pulse of energy to accomplish the treatment. e technique produces the same basic eect as sclerotherapy, and therefore the indications for treatment are very similar. Other energy-based options include infrared coagula­tion and therapy with direct current (Ultroid; Ultroid Technologies, Inc., Tampa, Fla.). Infrared coagulation employs a tungsten halogen lamp that generates heat energy, generally for a 1.5-second period at a depth of penetration of 3 mm. Direct-current therapy uses electri­cal current applied for up to 10 minutes per complex treated. ere is probably no advantage of one technique over the other, although

EXCISIONAL HEMORRHOIDECTOMY

An excisional hemorrhoidectomy is indicated when the degree of prolapse of the internal hemorrhoids is too great to allow eective banding—that is, the bands themselves would ride up and down on the prolapsing hemorrhoids and would be too far away from the sub­mucosa to x the mucosa. Surgery eectively corrects the associated prolapse, bleeding, discomfort, anal seepage, and diculties with anal hygiene. Excisional hemorrhoidectomy is the only option for gangrenous internal hemorrhoids.
Several techniques have been described for excisional hem­orrhoidectomy, including the Milligan-Morgan technique, the
HemorrHoids14
Ferguson closed hemorrhoidectomy, the Whitehead hemorrhoidec­tomy, and the more recently described stapled hemorrhoidectomy (or stapled hemorrhoidopexy). e procedures are usually per­formed in the operating theater aer minimal preoperative prepara­tion of the bowel, and excision can be performed with or without energy devices. e use of lasers for excisional hemorrhoidectomy oers no advantage and in fact causes delayed healing, increased pain, and increased cost.
e anesthesiologist and patient usually decide which type of anesthetic will be used; however, a local anesthetic supplemented by the administration of intravenous narcotics and propofol is highly eective and short acting. e use of spinal anesthesia, although eec­tive, may increase the risk of postoperative urinary retention because of a higher intraoperative administration of intravenous uids.
e Milligan-Morgan hemorrhoidectomy, which is widely practiced and described in Europe, includes resection of the entire enlarged internal hemorrhoid complex, ligation of the arterial ped­icle, and preservation of intervening anoderm. e incision in the anal canal and perianal skin is le open.
e closed Ferguson hemorrhoidectomy oers the benet of pri­mary wound closure with similar safety and ecacy. e following technical tips are related to the procedure: the entire internal/external hemorrhoidal complex should be removed with an hourglass-shaped excision (centered at the mid portion of the anoderm) with limited anoderm removal; the internal and external anal sphincters should be preserved; and primary closure of the entire wound should be per­formed. Occasionally it is necessary to undermine aps of anoderm and perianal skin to allow removal of intermediate hemorrhoidal tis­sue while preserving the bridges of anoderm between pedicles.
e Whitehead hemorrhoidectomy was devised to eradicate the enlarged internal hemorrhoidal tissue circumferentially with advancement of the prolapsed dentate line proximally to reconstruct the anal canal lining. is technique has been largely abandoned because of the high rates of mucosal ectropion and anal stricture resulting from the complexity of reconstruction.
Instrumentation for Excisional Hemmorrhoidectomy
e increasingly critical emphasis on cost-eectiveness requires a thoughtful assessment of the need for advanced instrumentation in hemorrhoidectomy. e ecacy of conventional surgery is unques­tioned, whereas the benets of considerably more expensive energy devices are mostly theoretical. Standard monopolar electrocautery is relatively inexpensive and can be useful to control nuisance bleed­ing from the wound edges and small vessels. Suture ligation of the main pedicle is still required, and thermal spread is associated with increased pain.
Laser technology has been evaluated both as a means of cutting hemorrhoidal tissue and as a technique for ablation, but it is simply another way of causing tissue destruction. Although some authors have suggested that patients experience less pain with the use of Nd:YAG laser for excision and coagulation, a prospective random­ized trial demonstrated greater pain and slower healing when com­pared with sharp dissection.
A bipolar cautery device capable of simultaneous tissue division and blood vessel coagulation has been compared with monopo­lar diathermy hemorrhoidectomy, with most of the data suggesting reductions in operative time and early postoperative pain. A meta­analysis compared hemorrhoidectomy with LigaSure (Medtronic, Minneapolis, Minn.) to conventional excisional techniques and found similar cure rates but shorter operative time, decreased pain, shorter time to wound healing, and less time o from work. A com­peting technology is the Harmonic scalpel (Ethicon Endo-Surgery, Cincinnati, Ohio), which relies on a rapidly reciprocating blade to generate heat for coagulation and tissue transection. Experience with the Harmonic scalpel suggests low rates of postoperative hemorrhage
(0.6%), urinary retention (2%), ssure (1%), and abscess/stula (0.8%). Several subsequent prospective, randomized comparisons of diathermy with the Harmonic scalpel failed to conrm any dier­ences between the two tools. 

PROCEDURE FOR PROLAPSING HEMORRHOIDS (STAPLED HEMMORHOIDOPEXY)

Another option for advanced hemorrhoidal disease is the procedure for prolapsing hemorrhoids (PPH), which utilizes a circular stapler to reduce and x the hemorrhoidal complex. e technique entails placement of a transanal purse-string suture 0.5 cm above the top of the hemorrhoidal complex to allow partial resection of the rectal mucosa in the less sensitive distal rectum above the hemorrhoidal tissue, with repositioning of both the anoderm and hemorrhoidal columns to the appropriate locations. Prospective randomized tri­als have been performed to compare this approach with excisional hemorrhoidectomy, although interest in the United States appears to be waning. Most of the data support the concept that PPH is associ­ated with a lesser degree of early postoperative pain and a general reduction in the duration of this pain aer surgery. Giordano and colleagues addressed the question of long-term outcome for PPH, demonstrating a signicantly higher rate of prolapse recurrence in the PPH group and a higher rate of further treatment to correct recur­rent prolapses compared with conventional hemorrhoidectomy. An additional concern associated with PPH is the risk of either closure of the rectal lumen as a result of failure to place the anvil proximal to the purse-string suture or sepsis as a result of rectal wall perforation. ese complications can be life threatening and are dicult to correct and have reduced interest in the procedure in some circles. 

DOPPLER-GUIDED HEMORRHOIDAL DEARTERIALIZATION

A new technique that is gaining popularity is Doppler-guided hemor­rhoidal artery ligation, or transanal hemorrhoidal dearterialization (THD). e Doppler-guided technique provides simultaneous reduction of the arterial blood ow, reduction of the prolapse (or mucopexy), and tissue destruction by oversewing the reduced hem­orrhoidal tissue. A specically designed proctoscope is used coupled with a Doppler transducer. At the distal end a small window allows suturing of the rectal mucosa 2 to 3 cm above the dentate line. e reduction of blood ow is thought to lead to shrinkage of the hemor­rhoidal complex. In addition, a hemorrhoidopexy can be performed that lis up the prolapsing tissue into its normal anatomic position. Giordano and colleagues published an extensive review of the current evidence on THD, looking specically at safety and eectiveness of the technique. e technique appears safe and ecacious in trained hands, but it relies primarily upon suture plication of the hemor­rhoidal complexes associated with reduction of the prolapse rather than excision of tissue. erefore, it may be less painful than other techniques but requires additional operative cost for the disposable equipment. 

POSTOPERATIVE MANAGEMENT AFTER HEMORRHOID SURGERY

Postoperative management is primarily focused on eective anal­gesia and avoidance of urinary retention and constipation. Options include a combination of oral and parenteral narcotics, nonsteroi­dal agents, and local anesthetic blocks. Ketorolac has demonstrated considerable ecacy in managing posthemorrhoidectomy pain. e use of alternative administration routes for narcotics either by patch or subcutaneous pump has been successful in controlling
ANAL AND PERIANAL REGION 15
pain; however, the management of these routes of administra­tion can be risky in the outpatient setting because of the risk of narcotic-induced respiratory depression, and therefore it is not recommended.
Urinary retention is a frequent postoperative problem aer hem­orrhoidectomy, ranging in incidence from 1% to 52%. A variety of strategies have been used to treat the problem; the optimal approach is prevention by limiting perioperative uid administration to 250 mL and avoiding both spinal anesthesia and anal packing.
Early postoperative bleeding (within <24 hours) occurs in approx­imately 1% of cases and represents a technical issue requiring a return to the operating theater for resuturing of the wound. Delayed hemor­rhage occurs in 0.5% to 4% of cases at 5 to 10 days aer surgery. e cause is thought to be early separation of the ligated pedicle before adequate thrombosis in the feeding artery can occur. e bleeding in this scenario is usually signicant and requires some method for control of ongoing hemorrhage. Options include a return to the oper­ating theater for suture ligation or tamponade at the bedside with a Foley catheter or anal packing. 

CONCLUSION

e management of symptomatic hemorrhoidal disease should be adapted to the clinical presentation of the patient and the severity of the symptoms. e vast majority of patients can be managed in an oce setting, oen without any procedure at all. When some form of active treatment is needed, the most appropriate option is selected based on the anatomy of the hemorrhoids in question and the symp­toms reported by the patient.

S u g g e S t e d R e a d i n g

Andrews E. Disastrous results following Whitehead’s operation and the so-
called American operation. Columbus Med J. 1895;15:97–106. Armstrong DN, Frankum C, Schertzer ME, et al. Harmonic scalpel
hemorrhoidectomy: ve hundred consecutive cases. Dis Colon Rectum.
2002;45:354–359.
Bayer I, Myslovaty B, Picovsky BM. Rubber band ligation of hemorrhoids:
convenient and economic treatment. J Clin Gastroenterol. 1996;23:50–52.
Dennison AR, Whiston RJ, Rooney S, etal. A randomized comparison of
infrared photocoagulation with bipolar diathermy for the outpatient treat­ment of hemorrhoids. Dis Colon Rectum. 1990;33:32–34.
Ferguson JA, Heaton JR. Closed hemorrhoidectomy. Dis Colon Rectum.
1959;2:176–179.
Franklin EJ, Seetharam S, Lowney J, Horgan PG. Randomized, clinical trial of
LigaSure versus conventional diathermy in hemorrhoidectomy. Dis Colon Rectum. 2003;46:1380–1383.
Ganchrow MJ, Mazier WP, Friend WG, Ferguson JA. Hemorrhoidectomy re-
visited: a computer analysis of 2038 cases. Dis Colon Rectum. 1971;14:128–
133.
Ganio E, Altomoare DF, Gabrielli F, et al. Prospective randomized multi-
centre trial comparing stapled with open haemorrhoidectomy. Br J Surg. 2001;88:669–674.
Goligher JC. Haemorrhoids or piles. In: Goligher JC, Duthie HL, Homewood
Nixon H, eds. Surgery of the Anus, Rectum and Colon. 5th ed. London: Baillière Tindall; 1984:98–149.
Haas PA, Fox TA, Haas GP. e pathogenesis of hemorrhoids. Dis Colon Rec-
tum. 1984;27:442–450.
Mado RD. Biblical management of anorectal disease. Breckenridge, CO:
Presented at the meeting of the Midwest Society of Colon and Rectal Sur­geons; March 1991.
Morgado PJ, Suarez JA, Gomez LG, etal. Histoclinical basis for a new clas-
sication of hemorrhoidal disease. Dis Colon Rectum. 1988;31:474–480.
Scarpa FJ, Hillis W, Sabetta JR. Pelvic cellulitis: a life-threatening complica-
tion of hemorrhoidal banding. Surgery. 1988;103:383–385.
Senagore A, Mazier WP, Luchtefeld MA, et al. e treatment of advanced
hemorrhoidal disease: a prospective randomized comparison of cold scal­pel versus contact Nd:YAG laser. Dis Colon Rectum. 1993;6:1042–1049.
Senagore AJ, Singer MS, Abcarian H, etal. A prospective, randomized, con-
trolled multicenter trial comparing stapled hemorrhoidopexy and Fer­guson hemorrhoidectomy: perioperative and one-year results. Dis Colon Rectum. 2004;47:1824–1836.
Taj an a A . Hemorrhoidectomy according to Milligan-Morgan: ligature and ex-
cision technique. Int Surg. 1989;74:158–161. Whitehead W. e surgical treatment of hemorrhoids. BMJ. 1882;1:148–150. Wrobleski DE, Corman ML, Veidenheimer MC, Coller JA. Long-term evalu-
ation of rubber ring ligation in hemorrhoidal disease. Dis Colon Rectum.
1980;23:478–482.
C A F
Siraj Rajaratnam and Ian Lindsey

INTRODUCTION

An anal ssure is a linear tear in the lining of the anal canal that usually becomes symptomatic because it exposes the internal anal sphincter and causes painful spasms in that muscle. An anal ssure is a common condition that signicantly disturbs the quality of life of persons who experience it.
Most ssures are benign, primary, and idiopathic—that is, they are typical anal ssures. Atypical ssures are much less common and occur as a result of other conditions such as Crohn disease, immunosuppression (including human immunodeciency virus), malignancy, syphilis, or tuberculosis, or they are drug induced (e.g., through the use of nicorandil). An atypical ssure is painless, not situated in the midline, multiple, or associated with a mass or a stula-in-ano. Management of atypical ssures involves treating the underlying condition and is beyond the scope of this chapter.
Typical ssures can be arbitrarily classied into acute and chronic on the basis of duration of symptoms: chronic ssures have been present for more than 6 weeks. However, certain features are associ­ated with chronic ssures, and the presence of one or more of these features is possibly a more accurate indicator of chronicity than the duration of symptoms alone.
Acute ssures are managed with a high-ber diet, stool soen­ers, and topical local anesthetic ointment. ey will not be discussed further. is chapter will focus on the clinical assessment, patho­physiologic features, and management of typical chronic anal ssures (CAFs). 

DIAGNOSIS

e diagnosis of CAF can be suspected based on the patient’s his­tory and conrmed with clinical examination. e patient usually reports having severe, sharp pain at defecation that persists for sev­eral minutes to hours aerward and then slowly subsides, with mini­mal discomfort experienced at other times of the day. CAF is oen associated with a small amount of bright red blood on the toilet tis­sue. e patient oen has a history of constipation and straining to defecate.
Upon examination, the following features of a CAF are observed:
1. A linear ulcer with a brotic rolled edge; the circular muscle
bers of the internal anal sphincter are visible at the base of the ulcer, and minimal granulation tissue is present.
2. A sentinel skin tag at the caudal (external) apex of the ssure.
3. A hypertrophied anal papilla at the internal apex.
CAF occurs in the midline and is usually posterior but may be anterior. Fissures away from the midline are atypical.
e caudal end of the ssure oen can be seen upon gentle sepa­ration of the buttocks. Digital examination and proctoscopy will
16
conrm the diagnosis but are unlikely to be tolerated because of anal spasm and pain. An anal block will allow anoscopy, but with the combination of a typical history and a “shy” anus, it is reason­able to begin empiric management and perform an examination at a later date when symptoms have improved. However, if the his­tory is atypical, examination should be undertaken with use of an anesthetic.
Endoanal ultrasonography and manometry are not necessary in the initial workup but may be useful prior to considering more invasive treatment options if first-line conservative treatment fails. 

PATHOPHYSIOLOGY

Shearing forces created by passage of hard stool, childbirth, instrumentation of the anus, or anal intercourse leads to the devel­opment of a split in the anal canal mucosa. If this split exposes the internal anal sphincter, an acute fissure is present. There are probably two different mechanisms by which an acute fissure may progress to CAF.
High-Pressure Chronic Anal Fissure
Although the exact pathophysiology of CAF remains obscure, a baseline hypertonia of the internal anal sphincter appears to be the most important factor, particularly in posterior CAF. Patients with posterior CAF have been shown to have higher mean resting anal pressures than do control subjects. Whether the hypertonia is the cause of the CAF or a secondary phenomenon caused by pain is not clear. Nevertheless, treatment of internal sphincter hyperto­nia remains the focus of management and therefore must at least be central to the persistence of CAF. Sphincter hypertonia leads to reduced perfusion pressure of the anal canal, which is more pronounced posteriorly as a result of a relative paucity of small arterioles supplying the posterior anal canal. This phenomenon has been shown in anatomic studies of normal subjects. Reduc­tion of anal pressure by either medical or surgical means is aimed at improving mucocutaneous blood flow, resulting in healing of the fissure. 
Low- and Normal-Pressure Chronic Anal Fissure
Manometric studies have shown that up to 50% of patients with CAF do not have increased anal pressures. ese patients are typically women with anterior midline CAF, which, in small studies, has been associated with vaginal delivery, external sphincter injury/dysfunc­tion, rectocele, and rectoanal intussusception. 
ANAL AND PERIANAL REGION 17

MANAGEMENT

Until 20 years ago, surgery was the mainstay of treatment of CAF. Manual dilatation of the anus and internal anal sphincterotomy were the principal surgery therapies; however, increasing focus on permanent incontinence caused by surgery and the development of safer conservative treatments have led to a signicant change in CAF management.
Manual dilatation has been used for almost 200 years. A reduc­tion in anal pressure is achieved by tearing the bers of the internal sphincter by stretching aer induction of general anesthesia. is stretching is traditionally performed with the surgeon’s ngers and is a relatively uncontrolled way of relieving sphincter spasm. Indeed, the disruption of the sphincter mechanism (especially that caused by an eight-nger dilatation) carries an unacceptable risk of perma­nent incontinence. In a 2011 Cochrane review that included seven studies of manual dilatation versus sphincterotomy, it was found that the risk of atus incontinence or fecal seepage was as high as 27% in the dilatation group, with an odds ratio of 4.03 (95% condence interval [CI], 2.04 to 7.46) when compared with sphincterotomy. In addition, dilatation is less eective for ssure healing compared with sphincterotomy, with an odds ratio of 1.55 (95% CI, 0.85 to 2.86) for persistence of the ssure, leading to the recommendation that use of manual dilatation to treat CAF in adults be abandoned.
Although internal sphincterotomy still has a role in the manage­ment of CAF, it also carries a signicant risk of permanent inconti­nence and therefore is not the rst-line option.
Topical Creams
Topical creams containing glyceryl trinitrate (GTN) or calcium chan­nel blockers in combination with a stool soener are now established as the rst-line treatment for CAF. erapy may be initiated by the primary care physician without the need for specialist assessment or an anesthetic and with no risk of permanent incontinence.
e most commonly used topical cream is GTN, which causes vasodilation and relaxation of the internal sphincter muscle via stimulation of guanylate cyclase and lowering of cytosolic calcium. A 0.2% cream is applied directly to the anoderm three times daily for 8 weeks. Symptoms may improve signicantly aer just 1 or 2 weeks, but the full course should be completed to achieve mucocuta­neous healing. Although there is no risk of permanent incontinence, patients can be troubled by adverse eects such as headache (in up to 50% of cases) as a result of absorption of GTN into the systemic circulation. is adverse eect may lead to noncompliance because the headache can be severe and unresponsive to simple analgesics.
e ecacy of GTN cream was assessed in a 2012 Cochrane review. Healing rates of 48.9% for GTN versus 35.5% for placebo were found in a meta-analysis of 18 randomized controlled trials that included a total of 1315 patients. Although this result is statistically signicant, it demonstrates that more than half of patients will have persistent CAF aer treatment with GTN. e reasons for this lack of response to GTN are unclear but probably multiple. Noncompliance, whether as a result of headache or for other reasons, and tachyphy­laxis are possible explanations. Another likely cause of recurrence is persistent hypertonia of the internal sphincter that makes the patient “ssure prone.” ese patients may respond to treatment initially, only to quickly relapse once the resting anal pressure returns to nor­mal at the conclusion of the treatment. Other patients may never exhibit a reduction in resting pressure despite treatment with GTN. It also has been demonstrated that patients with long-established CAF are less likely to respond to GTN. In a case series of 64 patients, the presence of a sentinel tag (P <.035) and symptom duration of greater than 6 months (P <.05) were found to be independent predictors of treatment failure. Various doses of GTN cream have been tested, ranging from 0.05% to 0.4%, but the dose has not been found to alter healing rates.
Calcium channel blockers also cause smooth muscle relaxation, thus lowering resting anal pressure. As with GTN, there is also a vasodilator eect, further contributing to improved mucocutaneous blood ow. Diltiazem and nifedipine have been studied using both oral and topical preparations. A 2% diltiazem cream is the most commonly used preparation and is applied topically in the same manner as GTN—three times daily for 8 weeks. A meta-analysis of seven randomized trials (including 481 patients) comparing topi­cal diltiazem and topical GTN found an equal chance of healing (relative risk [RR] = 1.10, P < .36), although diltiazem was superior with regard to overall adverse eects (RR = 0.48, P <.01), headache (RR = 0.39, P <.0004), and recurrence of CAF (RR = 0.68, P <.006). Heterogeneity among the trials was signicant. Nevertheless, this evidence supports the use of diltiazem before the use of GTN. 
Botulinum Toxin
Botulinum toxin A (BTX) is a neurotoxin produced by Clostridium botulinum. It acts on striated muscle by blocking acetylcholine release
at the neuromuscular junction—hence its established role in the treat­ment of hypertonic skeletal muscle disorders and cosmetic medicine. Its action on smooth muscle such as the internal anal sphincter is less clear. In a study of animal subjects it was found that BTX causes a reduction in noradrenaline release from sympathetic nerves within the internal sphincter and possibly blocks acetylcholine release in the sympathetic relay ganglion in the vicinity of the muscle, thus reducing myogenic tone.
BTX injection is a minimally invasive option for the treatment of CAF with the aim of reducing resting anal pressure suciently to allow healing but only for a temporary period (2 to 4 months); conse­quently, any eect on continence is short-lived.
We inject BTX in the outpatient clinic aer performing a local anesthetic anal block (10 mL of 0.5% bupivacaine and 10 mL of 1% lignocaine). When the procedure is combined with a ssurectomy (described in the next section), it is performed aer induction of gen­eral anesthesia. A total of 20 to 40 units of Botox (Allergan, Parsip­pany, N.J.) or 100 to 200 units of Dysport (Galderma Laboratories, Lausanne, Switzerland) is mixed with saline solution and injected with a ne-bore (27-gauge) needle. We inject a divided dose directly into the internal sphincter on either side of the midline either anteri­orly or posteriorly (depending on the location of the ssure). A num­ber of alternative methods have been described, including unilateral injection, more than two injection sites, and injection into the exter­nal anal sphincter, without evidence to suggest that any one method is best. Given what we know about the mechanism of action of BTX, it seems logical to inject it either into the internal anal sphincter or intersphincteric space.
BTX injection is generally well tolerated, and adverse eects such as temporary incontinence, urgency, and perianal hematoma are infrequent. e major advantage of BTX is that it does not have the compliance issues associated with topical creams because a one-o injection is all that is required. Unfortunately, this does not translate into improved healing rates. In a Cochrane meta-analysis of six studies (including 334 patients), BTX was found to be equiva­lent to GTN, and therefore use of BTX as rst-line therapy cannot be justied given its increased cost. However, evidence shows that BTX can be eective in patients who have not responded to initial management with GTN. 
Fissurectomy
e presence of chronic brosis may be an important factor in patients who do not respond to medical therapy. Fissurectomy—that is, exci­sion of the CAF complex (the hypertrophied anal papilla, sentinel tag, and brotic scar tissue), thus exposing the healthy underlying inter­nal sphincter with freshened wound edges—treats the chronic brosis
ChroniC AnAl Fissure18
while sparing the sphincter. Fissurectomy alone was shown to result in excellent healing rates in a case series of 118 patients, but we believe it is most eective when used in conjunction with medical treatment of sphincter hypertonia. irty patients who had not responded to medical management (19 who were treated with GTN and 11 who were treated with GTN followed by BTX) underwent a ssurectomy in combination with a BTX injection. e healing rate was 93% at a median of 16.4 weeks follow-up, and even the patients who did not heal (n = 2) had signicant symptomatic improvement. ere were no cases of fecal incontinence and just two patients (7%) reported atus incontinence, which, in both cases, resolved within 6 weeks. 
Cutaneous Advancement Flap
Aer a ssurectomy has been performed, advancing a healthy ap of perianal skin into the defect appears to be a safe and eec­tive treatment. It is certainly appropriate in persons with low- or normal-pressure ssures (who are less likely to have responded to medical treatment), but it is also a good option in persons with high-pressure CAF who may be at particular risk of incontinence upon undergoing a sphincterotomy, such as women, older persons, persons with pre-existing continence disturbance, and persons found to have a sphincter defect on ultrasound.
V-shaped incisions or rhomboid incisions are made with the fur­thest extent of the incision approximately 4 cm from the anal verge. e skin must be mobilized suciently to allow advancement of the ap into the anal canal without tension, while maintaining the vascu­lar pedicle to the ap through the subcutaneous fat underneath. e ap is secured over the ssure using interrupted, rapidly absorbable, braided sutures.
In a series of 54 patients, a V-Y advancement ap led to immediate healing in 94% of subjects, and the healing rate was 85% with place­ment of a rhomboid advancement ap in a randomized trial of 40 patients in which this procedure was compared with sphincterotomy (100%, P = not signicant). e median operating time in the group that received the ap was 10 minutes. 
Lateral Internal Sphincterotomy
Lateral internal sphincterotomy (LIS) remains the single most eec­tive treatment for CAF in terms of ssure healing (>90%). Sphinc­terotomy has been practiced for 200 years but was popularized by Eisenhammer in the 1950s. Eisenhammer divided the internal sphincter in the posterior midline at the base of the ssure, which resulted in signicant postoperative pain, prolonged healing, and a “keyhole” deformity that was associated with poor continence. e technique of sphincterotomy was later rened by Notaras, who described lateral division of the internal sphincter, which results in fewer complications.
Surgical Technique
LIS can be performed in the lithotomy or prone jackknife posi­tion after induction of general, regional, or local anesthesia. Bowel preparation and antibiotic prophylaxis are not necessary. After preparing and draping the perianal region, a Pratt bivalve speculum or similar anal retractor is inserted into the anus and the intersphincteric groove is palpated. A short circumferential incision is made laterally at either 3 or 9 o’clock, and the internal sphincter is identified. Submucosal and intersphincteric planes are developed to isolate the internal sphincter, which may then be divided under direct vision. The caudal part of the internal sphincter is divided for a variable distance cranially, usually to the dentate line. The wound may be closed with fine absorbable inter­rupted sutures or may be left open. Routine postoperative care typically includes a stool-bulking agent and nonopiate analgesia.
A closed or subcutaneous sphincterotomy is a slight modica­tion of the open procedure and leaves a tiny perianal wound. With a Pratt’s retractor or nger in the anal canal, a scalpel is inserted in a lateral position at the intersphincteric groove and advanced cephalad in either the submucosal or intersphincteric planes. e blade is then turned laterally (if submucosal) or medially (if intersphincteric) to divide the internal sphincter while feeling the characteristic “give” as the tension in the muscle is released. e blade is removed, hemosta­sis is achieved with pressure, and the wound is le open. 
Risk of Incontinence
Although LIS certainly works in achieving CAF healing, inconti­nence rates of up to 30% have been reported. In a meta-analysis of 22 studies (including 4512 patients) that entailed use of open and closed LIS techniques and with a minimum follow-up of 2 years, an overall continence disturbance rate of 14% was reported. e follow­ing rates were reported: atus incontinence, 9%; soilage/seepage, 6%; accidental defecation, 0.91%; incontinence to liquid stool, 0.67%; and incontinence to solid stool, 0.83%. Concerns regarding perma­nent incontinence aer LIS are real and signicant. Furthermore, evidence shows that delayed-onset incontinence may occur, analo­gous to the development of fecal incontinence many years aer an obstetric injury. 
Tailored Sphincterotomy
A tailored sphincterotomy refers to various technical modications aimed at reducing the risk of incontinence with LIS by dividing the minimum amount of internal sphincter required to achieve CAF healing. In 1997, Littlejohn and Newstead published a report on a series of 287 patients who underwent LIS that was tailored to stop at the internal apex of the ssure rather than going up to the dentate line as traditionally described. is method of tailored LIS is the most commonly reported and is what we recommend if LIS is to be undertaken. Littlejohn and Newstead reported excellent results: the rates of healing, atus incontinence, minor soiling, and urgency were 99.65%, 1.4%, 0.35%, and 0.7%, respectively. ese results have been supported by a subsequent randomized controlled trial using the same tailored LIS technique. Incontinence rates were 2.17% ver­sus 10.86% in the traditional LIS group (P = .039). Healing rates in the tailored LIS group were slightly lower (but not signicantly so) and were still excellent (95.65%). 
Treatment of Low/Normal Pressure
Chronic Anal Fissure
Nineteen percent of men and 42% of women with CAF have low or normal resting anal pressures. Performing LIS in this group of patients would seem illogical, yet it is unclear how LIS can achieve overall healing rates of greater than 90% because most reports of LIS do not exclude this subgroup. Nevertheless, we do not recommend LIS for low- or normal-pressure CAF because these patients must be at a signicant risk of incontinence with a surgical reduction in rest ing pressure of 25% (which is normally achieved with LIS).
Low- and normal-pressure CAFs appear to have dierent patho­physiologic features compared with high-pressure CAFs (as previ­ously discussed). ese patients are less likely to respond to topical smooth muscle relaxants and may even show an atypical contractile response of the internal sphincter to BTX. Fissurectomy with or with­out cutaneous advancement ap is the surgical treatment of choice for these patients. If this treatment fails, underlying anorectal dys­function, such as rectocele and rectoanal intussusception, should be considered, and appropriate investigation and management should be undertaken. Successful treatment of CAF in highly selected patients has been reported with levatorplasty, stapled transanal rectal resection, and sacral neuromodulation. 
-
ANAL AND PERIANAL REGION 19
Female with anterior fissure Preexisting incontinence Older age group
Significant chronic fibrosis
Topical GTN 0.2% cream (or Diltiazem 2% if intolerant to GTN)
No significant fibrosis
BTX injection
under local anaesthesia
Advancement flap
Anal manometry
and ultrasound
High fiber diet, Stool-softener
Fissurectomy and BTX injection
under general anaesthesia
Male with
High resting pressure

SUMMARY: CHOICE OF TREATMENT

CAF is a common condition with several treatment options. Although a large volume of literature exists regarding CAF, making sense of it in clinical practice is somewhat dicult because of dier­ences in technique and use. Many studies directly compare just two therapeutic options and are limited by a small sample size and a short follow-up period. In addition, the vast majority of investigators do not distinguish between high-pressure and low- or normal-pressure CAF, which appear to have dierent pathophysiologic features. Stud­ies of treatment algorithms would be more useful for a condition such as CAF. Management algorithms for CAF may reduce the need for LIS (as well as the associated risk of permanent incontinence) and reduce costs by targeting use of endoanal ultrasound and manom­etry. Our algorithm is presented in Figure 3-1.

S u g g e S t e d R e a d i n g

Aigner F, Conrad F. Fissurectomy for treatment of chronic anal ssures.
Dis Colo Rectum. 2008;51(7):1163.
Bove A, Balzano A, Perrotti P, etal. Dierent anal pressure proles in
patients with anal ssure. Tech Coloproctol. 2004;8(3):151–156.
Chambers W, Sajal R, Dixon A. V-Y advancement ap as rst-line treatment
for all chronic anal ssures. Int J Colorectal Dis. 2010;25:645–648.
Clarke A, Chand M, Tarver D, Nash G, Lamparelli M. Stapled transanal
rectal resection in the management of resistance anal ssures. Colorectal Dis. 2008;10(suppl 1):6.
Low or normal resting pressure
Investigate and treat
pelvic floor disorder
(e.g., rectocele, recto-
anal intussusception)
FIGURE 3-1 Management algorithm for chronic anal fissure. BTX, Botulinum toxin A; GTN, glyceryl trinitrate.
Corby H, Donnelly V, O’Herlihy C, O’Connell P. Anal canal pressures are
low in women with postpartum anal ssure. Br J Surg. 1997;84(1):86–88.
Ellis C. Anterior levatorplasty for the treatment of chronic anal ssures in
females with a rectocele: a randomised controlled trial. Dis Colon Rectum. 2004;47:1170–1173.
Elsebae M. A study of fecal incontinence in patients with chronic anal s-
sure: prospective, randomized, controlled trial of the extent of internal anal sphincter division during lateral sphincterotomy. World J Surg. 2007;31(10):2052–2057.
Essani R, Sarkisyan G, Beart R, etal. Ecacy of management algorithm for
reducing need for sphincterotomy in chronic anal ssures. J Gastrointest Surg. 2005;9:1237–1243.
Garg P, Garg M, Menon G. Long-term continence disturbance aer lateral
internal sphincterotomy for chronic anal ssure: a systematic review and meta-analysis. Colorectal Dis. 2013;15(3):e104–e117.
Gordon P. Fissure-in-ano. In: Gordon PH, Nivatvongs S, eds. Principles and
Practice of Surgery for the Colon, Rectum, and Anus. 3rd ed. New York:
Informa Healthcare USA; 2007:167–187. Herzig D, Lu K. Anal ssure. Surg Clin North Am. 2010;90:33–44. Jenkins J, Urie A, Molloy R. Anterior anal ssures are associated with oc-
cult sphincter injury and abnormal sphincter function. Colorectal Dis.
2008;10(3):280–285. Jones O, Brading A, Mortensen N. e mechanism of action of botulinum
toxin on the internal anal sphincter. Br J Surg. 2004;91:224–228. Jones O, Ramalingam T, Lindsey I, etal. Digital assessment of internal
sphincter spasm in chronic anal ssure is unreliable. Dis Colon Rectum.
2005;48:349–352. Klosterhalfen B, Vogel P, Rixen H, Mittermayer C. Topography of the infe-
rior rectal artery: a possible cause of chronic, primary anal ssure. Dis
Colon Rectum. 1989;32(1):43–52.
Tailored lateral
internal
sphincterotomy
ChroniC AnAl Fissure20
Leong A, Seow-Choen F. Lateral sphincterotomy compared with anal advance-
ment ap for chronic anal ssure. Dis Col Rectum. 1995;38(1):69–71.
Levin A, Choen M, Mindrul V. Delayed fecal incontinence following surgery
for anal ssure. Int J Colorectal Dis. 2011;26:1595–1599.
Lindsey I, Cunningham C, Jones O, etal. Fissurectomy-botulinum toxin: a
novel sphincter-sparing procedure for medically resistant chronic anal ssure. Dis Col Rectum. 2004;47(11):1947–1952.
Lindsey I, Jones O, Cunningham C. A contraction response of the internal
anal sphincter to Botulinum toxin: does low-pressure chronic anal ssure have a dierent pathophysiology? Colorectal Dis. 2011;13:1014–1018.
Littlejohn D, Newstead G. Tailored lateral sphincterotomy for anal ssure.
Dis Col Rectum. 1997;40(12):1439–1442.
Lund J, Scholeeld J. Aetiology and treatment of anal ssure. Br J Surg.
1996;83(10):1335–1344.
Lund J, Scholeeld J. Glyceryl trinitrate is an eective treatment for anal s-
sure. Dis Colon Rectum. 1997;40:468–470.
Nelson R, Chattopadhyay A, Platt I, etal. Operative procedures for ssure in
ano. Cochrane Database Syst Rev. 2011;11: CD002199.
Nelson R, omas K, Morgan J, Jones A. Non surgical therapy for anal
ssure. Cochrane Database Syst Rev. 2012;2:CD003431.
Pitt J, Williams S, Dawson P. Reasons for failure of glyceryl trinitrate treat-
ment of chronic ssure-in-ano: a multivariate analysis. Dis Col Rectum. 2001;44(6):864–867.
Sajid M, Whitehouse P, Sains P, Baig M. Systematic review of the use of
topical diltiazem compared with glyceryl trinitrate for the nonoperative management of chronic anal ssure. Colorectal Dis. 2012;15:19–26.
Schouten W, Briel J, Auwerda J. Relationship between anal pressure and ano-
dermal blood ow. e vascular pathogenesis of anal ssures. Dis Colon Rectum. 1994;37(7):664–669.
Sileri P, Stol V, Franceschilli L, etal. Conservative and surgical treatment
of chronic anal ssure: prospective long term study. J Gastrointest Surg. 2010;14(5):773–780.
Sinha R, Kaiser A. Ecacy of management algorithm for reducing need
for sphincterotomy in chronic anal ssures. Colorectal Dis. 2012;14: 760–764.
Wijels N, Cunningham C, Lindsey I. Rectoanal intussusception frequently
underlies recalcitrant chronic anal ssures. Colorectal Dis. 2008; 10(suppl 2):15.
Williams N, Scott N, Irving M. Eect of lateral sphincterotomy on internal
anal sphincter function. Dis Colon Rectum. 1995;38:700–704.
Yakovlev A, Karasev S, Dolgich O. Sacral nerve stimulation: a novel treat-
ment of chronic anal ssure. Dis Colon Rectum. 2011;54:324–327.